Alex Stevens

Alexander Stevens is an accomplished professional in the field of drug metabolism and pharmacokinetics, currently serving as the Director of DMPK at Sygnature Discovery since September 2022. Prior experience includes significant roles at Syngenta from April 2009 to September 2022, where positions varied from Product Safety Lead in the Research Portfolio Team to Principal Technical Expert and Senior Technical Expert in ADME. Prior to that, Alexander worked at GlaxoSmithKline as an Investigator in Discovery DMPK and PK/PD from January 2000 to June 2008. Alexander holds a PhD in Drug Metabolism & Pharmacokinetics from The University of Manchester, which was completed between 1994 and 1996.